Page last updated: 2024-08-25

clarithromycin and Benign Monoclonal Gammopathies

clarithromycin has been researched along with Benign Monoclonal Gammopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bricullé, M; Calvet, X; García, P; Gavarró, A; Gisbert, JP; Güell, M; Roig, I; Sanchez, J; Soler, JA; Villoria, A	1

Trials

1 trial(s) available for clarithromycin and Benign Monoclonal Gammopathies

Article	Year
H. pylori eradication does not reduce paraprotein levels in monoclonal gammopathy of unknown significance (MGUS): a prospective cohort study. Annals of hematology, 2009, Volume: 88, Issue:8 Topics: Aged; Aged, 80 and over; Clarithromycin; Cohort Studies; Female; Follow-Up Studies; Helicobacter pylori; Humans; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Paraproteins; Prospective Studies; Reproducibility of Results; Treatment Outcome	2009

Article

Year

H. pylori eradication does not reduce paraprotein levels in monoclonal gammopathy of unknown significance (MGUS): a prospective cohort study.

Annals of hematology, 2009, Volume: 88, Issue:8

Topics: Aged; Aged, 80 and over; Clarithromycin; Cohort Studies; Female; Follow-Up Studies; Helicobacter pylori; Humans; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Paraproteins; Prospective Studies; Reproducibility of Results; Treatment Outcome

2009